Microbiome Therapy for Neurological Disorders
Neuropsychiatric disorder are on the increase globally and, of the noncommunicable diseases, stand out as a leading cause of disability. Accruing evidence strongly links gut dysbiosis (gut microbiota–host maladaptation) as a risk factor in a wide range of mental illnesses that include neuropsychiatric conditions such as autism spectrum disorder (ASD), Alzheimer’s disease, epilepsy and schizophrenia among them. There are currently no drugs approved that treat the core symptoms of ASD.
We are creating lines of designer microbiomes with signature species and specific metabolic profile to enhance neurological pathologies of these diseases.